<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Immunol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Immunol</journal-id>
      <journal-id journal-id-type="hwp">jimmunol</journal-id>
      <journal-id journal-id-type="pmc">jimmunol</journal-id>
      <journal-id journal-id-type="publisher-id">JI</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Immunology Author Choice</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-1767</issn>
      <issn pub-type="epub">1550-6606</issn>
      <publisher>
        <publisher-name>AAI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25833397</article-id>
      <article-id pub-id-type="pmc">4416738</article-id>
      <article-id pub-id-type="publisher-id">ji_1402260</article-id>
      <article-id pub-id-type="doi">10.4049/jimmunol.1402260</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Immune Regulation</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rozanski</surname>
            <given-names>Cheryl H.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Utley</surname>
            <given-names>Adam</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carlson</surname>
            <given-names>Louise M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Farren</surname>
            <given-names>Matthew R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Murray</surname>
            <given-names>Megan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Russell</surname>
            <given-names>Lisa M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">†</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nair</surname>
            <given-names>Jayakumar R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>ZhengYu</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">‡</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brady</surname>
            <given-names>William</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">‡</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Garrett-Sinha</surname>
            <given-names>Lee Ann</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">†</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schoenberger</surname>
            <given-names>Stephen P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">§</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Green</surname>
            <given-names>Jonathan M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">¶</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Boise</surname>
            <given-names>Lawrence H.</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">‖</xref>
          <xref ref-type="aff" rid="aff7">#</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lee</surname>
            <given-names>Kelvin P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
          <xref ref-type="aff" rid="aff8">**</xref>
        </contrib>
        <aff id="aff1"><label>*</label>Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263;</aff>
        <aff id="aff2"><label>†</label>Department of Biochemistry, University at Buffalo, Buffalo, NY 14260;</aff>
        <aff id="aff3"><label>‡</label>Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY 14263;</aff>
        <aff id="aff4"><label>§</label>Laboratory of Cellular Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;</aff>
        <aff id="aff5"><label>¶</label>Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63130;</aff>
        <aff id="aff6"><label>‖</label>Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322;</aff>
        <aff id="aff7"><label>#</label>Department of Cell Biology, Emory University, Atlanta, GA 30322; and</aff>
        <aff id="aff8"><label>**</label>Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address correspondence and reprint requests to Dr. Kelvin P. Lee, Department of Immunology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. E-mail address: <email>Kelvin.Lee@RoswellPark.org</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>15</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <volume>194</volume>
      <issue>10</issue>
      <fpage>4717</fpage>
      <lpage>4728</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>9</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>3</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2015 by The American Association of Immunologists, Inc.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <copyright-holder>Copyright © 2015 by The American Association of Immunologists, Inc.</copyright-holder>
        <license license-type="open-access">
          <license-p>This article is distributed under The American Association of Immunologists, Inc., <ext-link ext-link-type="uri" xlink:href="http://www.jimmunol.org/site/misc/authorchoice.xhtml"><underline>Reuse Terms and Conditions for Author Choice articles</underline></ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>In health, long-lived plasma cells (LLPC) are essential for durable protective humoral immunity, and, conversely, in disease are a major source of pathogenic Abs in autoimmunity, graft rejection, and allergy. However, the molecular basis for their longevity is largely unknown. We have recently found that CD28 signaling in plasma cells (PC) is essential for sustaining Ab titers, by supporting the survival of LLPC, but not short-lived PC (SLPC). We now find that, unlike SLPC, CD28 activation in LLPC induces prosurvival downstream Vav signaling. Knockin mice with CD28 cytoplasmic tail mutations that abrogate Vav signaling (CD28-AYAA) had significantly fewer LLPC but unaffected SLPC numbers, whereas mice with mutations that abrogate PI3K signaling (CD28-Y170F) were indistinguishable from wild-type controls. This was consistent with the loss of CD28’s prosurvival effect in LLPC from CD28-AYAA, but not CD28-Y170F, mice. Furthermore, the CD28 Vav motif in the B lineage was essential for the long-term maintenance of Ag-specific LLPC populations and Ab titers in vivo. Signaling downstream of the CD28 Vav motif induced previously undescribed transcriptional regulation of B lymphocyte–induced maturation protein-1, a key mediator of PC differentiation and maintenance. These findings suggest CD28 signaling in LLPC modulates the central B lymphocyte–induced maturation protein-1 transcriptional nexus involved in long-term survival and function.</p>
      </abstract>
      <counts>
        <page-count count="12"/>
      </counts>
    </article-meta>
  </front>
</article>

